278 related articles for article (PubMed ID: 31541110)
1. Time elapsed between Zika and dengue virus infections affects antibody and T cell responses.
Pérez-Guzmán EX; Pantoja P; Serrano-Collazo C; Hassert MA; Ortiz-Rosa A; Rodríguez IV; Giavedoni L; Hodara V; Parodi L; Cruz L; Arana T; White LJ; Martínez MI; Weiskopf D; Brien JD; de Silva A; Pinto AK; Sariol CA
Nat Commun; 2019 Sep; 10(1):4316. PubMed ID: 31541110
[TBL] [Abstract][Full Text] [Related]
2. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
[TBL] [Abstract][Full Text] [Related]
3. Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection.
Valiant WG; Huang YS; Vanlandingham DL; Higgs S; Lewis MG; Mattapallil JJ
Emerg Microbes Infect; 2018 Jul; 7(1):130. PubMed ID: 30006514
[TBL] [Abstract][Full Text] [Related]
4. Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection.
Badolato-Corrêa J; Sánchez-Arcila JC; Alves de Souza TM; Santos Barbosa L; Conrado Guerra Nunes P; da Rocha Queiroz Lima M; Gandini M; Bispo de Filippis AM; Venâncio da Cunha R; Leal de Azeredo E; de-Oliveira-Pinto LM
Immun Inflamm Dis; 2018 Jun; 6(2):194-206. PubMed ID: 29282904
[TBL] [Abstract][Full Text] [Related]
5. Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus.
Pantoja P; Pérez-Guzmán EX; Rodríguez IV; White LJ; González O; Serrano C; Giavedoni L; Hodara V; Cruz L; Arana T; Martínez MI; Hassert MA; Brien JD; Pinto AK; de Silva A; Sariol CA
Nat Commun; 2017 Jun; 8():15674. PubMed ID: 28643775
[TBL] [Abstract][Full Text] [Related]
6. ELISPOT-Based "Multi-Color FluoroSpot" to Study Type-Specific and Cross-Reactive Responses in Memory B Cells after Dengue and Zika Virus Infections.
Andrade P; Coloma J; Harris E
Methods Mol Biol; 2018; 1808():151-163. PubMed ID: 29956181
[TBL] [Abstract][Full Text] [Related]
7. Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.
Grifoni A; Pham J; Sidney J; O'Rourke PH; Paul S; Peters B; Martini SR; de Silva AD; Ricciardi MJ; Magnani DM; Silveira CGT; Maestri A; Costa PR; de-Oliveira-Pinto LM; de Azeredo EL; Damasco PV; Phillips E; Mallal S; de Silva AM; Collins M; Durbin A; Diehl SA; Cerpas C; Balmaseda A; Kuan G; Coloma J; Harris E; Crowe JE; Stone M; Norris PJ; Busch M; Vivanco-Cid H; Cox J; Graham BS; Ledgerwood JE; Turtle L; Solomon T; Kallas EG; Watkins DI; Weiskopf D; Sette A
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978707
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
Front Immunol; 2018; 9():597. PubMed ID: 29740424
[TBL] [Abstract][Full Text] [Related]
9. Prior dengue virus serotype 3 infection modulates subsequent plasmablast responses to Zika virus infection in rhesus macaques.
Singh T; Miller IG; Venkatayogi S; Webster H; Heimsath HJ; Eudailey JA; Dudley DM; Kumar A; Mangan RJ; Thein A; Aliota MT; Newman CM; Mohns MS; Breitbach ME; Berry M; Friedrich TC; Wiehe K; O'Connor DH; Permar SR
mBio; 2024 Mar; 15(3):e0316023. PubMed ID: 38349142
[TBL] [Abstract][Full Text] [Related]
10. Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.
Roth C; Delgado FG; Simon-Lorière E; Sakuntabhai A
Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29473899
[TBL] [Abstract][Full Text] [Related]
11. Dengue Virus and Zika Virus Serological Cross-reactivity and Their Impact on Pathogenesis in Mice.
Watanabe S; Tan NWW; Chan KWK; Vasudevan SG
J Infect Dis; 2019 Jan; 219(2):223-233. PubMed ID: 30085051
[TBL] [Abstract][Full Text] [Related]
12. Cross-Reactive Dengue Virus Antibodies Augment Zika Virus Infection of Human Placental Macrophages.
Zimmerman MG; Quicke KM; O'Neal JT; Arora N; Machiah D; Priyamvada L; Kauffman RC; Register E; Adekunle O; Swieboda D; Johnson EL; Cordes S; Haddad L; Chakraborty R; Coyne CB; Wrammert J; Suthar MS
Cell Host Microbe; 2018 Nov; 24(5):731-742.e6. PubMed ID: 30439342
[TBL] [Abstract][Full Text] [Related]
13. Primary infection with dengue or Zika virus does not affect the severity of heterologous secondary infection in macaques.
Breitbach ME; Newman CM; Dudley DM; Stewart LM; Aliota MT; Koenig MR; Shepherd PM; Yamamoto K; Crooks CM; Young G; Semler MR; Weiler AM; Barry GL; Heimsath H; Mohr EL; Eichkoff J; Newton W; Peterson E; Schultz-Darken N; Permar SR; Dean H; Capuano S; Osorio JE; Friedrich TC; O'Connor DH
PLoS Pathog; 2019 Aug; 15(8):e1007766. PubMed ID: 31369649
[TBL] [Abstract][Full Text] [Related]
14. Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans.
Delgado FG; Torres KI; Castellanos JE; Romero-Sánchez C; Simon-Lorière E; Sakuntabhai A; Roth C
Viruses; 2018 Sep; 10(9):. PubMed ID: 30205518
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
[TBL] [Abstract][Full Text] [Related]
16. Human antibody response to Zika targets type-specific quaternary structure epitopes.
Collins MH; Tu HA; Gimblet-Ochieng C; Liou GA; Jadi RS; Metz SW; Thomas A; McElvany BD; Davidson E; Doranz BJ; Reyes Y; Bowman NM; Becker-Dreps S; Bucardo F; Lazear HM; Diehl SA; de Silva AM
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996133
[TBL] [Abstract][Full Text] [Related]
17. Pre-existing T Cell Memory against Zika Virus.
Schouest B; Grifoni A; Pham J; Mateus J; Sydney J; Brien JD; De Silva AD; Balmaseda A; Harris E; Sette A; Weiskopf D
J Virol; 2021 May; 95(12):. PubMed ID: 33789994
[TBL] [Abstract][Full Text] [Related]
18. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
[TBL] [Abstract][Full Text] [Related]
19. Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection.
Collins MH; McGowan E; Jadi R; Young E; Lopez CA; Baric RS; Lazear HM; de Silva AM
Emerg Infect Dis; 2017 May; 23(5):773-781. PubMed ID: 28418292
[TBL] [Abstract][Full Text] [Related]
20. Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population.
Montecillo-Aguado MR; Montes-Gómez AE; García-Cordero J; Corzo-Gómez J; Vivanco-Cid H; Mellado-Sánchez G; Muñoz-Medina JE; Gutiérrez-Castañeda B; Santos-Argumedo L; González-Bonilla C; Cedillo-Barrón L
J Immunol Res; 2019; 2019():7239347. PubMed ID: 31565661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
